Researchers found a 100 percent increase in production of key angiogenic factors from osteoblast cells cultured on the Titan Spine surface versus PEEK.
The study will be published in the next issue of The Spine Journal.
More Articles on Devices:
Medical Device Company DFINE Names Greg Barrett as President, CEO
NuVasive Spine Foundation Raises $230k for Improving Care of Global Patients in Need
Aurora Spine Completes IPO, Earns $3.61M for Lumbar Fusion Device Development
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
